Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it has secured rights to distribute the new 1POT™ Professional Device (the “1POT”)
Toronto, Ontario Dec 23, 2021 (Issuewire.com) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTCQB: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it has secured rights to distribute the new 1POT™ Professional Device (the “1POT”) and 1copy™ COVID-19 MDx Kit Professional (the “MDx Kit”).
Both the 1POT and MDx Kit provide together an accurate result eight times faster than a conventional RT-PCR test through the 1POT Professional app (the “App”). They open doors to rapid and convenient COVID-19 testing in places such as hospitals, clinics, and schools where healthcare professionals are present.
“The company is pleased with this new state-of-the-art testing system, opening the door to new revenue streams. A regular lab-based PCR test can be substituted with the MDx kit,” said Andrew Ryu, Chairman of the Company.
“With the new mutations of the virus popping up around the world including the highly contagious Omicron (B.1.1.529) variant, management feels that constant COVID-19 testing will be essential for the immediate future as part of the response to keep people secure and healthy. It is now time to join with Datametrex and the MDx Kit to expand COVID-19 testing for your neighbourhood and effectively prevent the further spread of the global pandemic,” said Marshall Gunter, Chief Executive Officer of the Company.
The MDx Kit has CE marking certification (“CE“) for European Economic Area (“EEA”) countries, which covers the 27 member states of the EU, the 4 members of EFTA, plus Turkey and the United Kingdom.
Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com). Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies. By working with companies to set a new standard of protocols through Artificial Intelligence and health diagnostics, Company provides progressive solutions to support the supply chain.
For additional information on Datametrex and other corporate information, please visit the Company’s website at www.datametrex.com.
For further information, please contact:
Andrew Ryu – Chairman
Marshall Gunter – CEO
Phone: (514) 295-2300